These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 5359922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acute myocardial infarction in man. Comparative hemodynamic effects of norepinephrine and glucagon.
    Diamond G, Forrester J, Danzig R, Parmley WW, Swan HJ.
    Am J Cardiol; 1971 Jun; 27(6):612-6. PubMed ID: 5092474
    [No Abstract] [Full Text] [Related]

  • 3. Effects of glucagon on myocardial contractility and hemodynamics in acute experimental myocardial infarction. Basis for its possible use in cardiogenic shock.
    Puri PS, Bing RJ.
    Am Heart J; 1969 Nov; 78(5):660-8. PubMed ID: 5348748
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of glucagon.
    Murtagh JG, Binnion PF, Lal S, Hutchison KJ, Fletcher E.
    Br Heart J; 1970 May; 32(3):307-15. PubMed ID: 5420074
    [Abstract] [Full Text] [Related]

  • 6. [Digitalis in myocardial infarct].
    Strauer BE.
    Med Klin; 1975 Nov 28; 70(48):1937-46. PubMed ID: 813102
    [No Abstract] [Full Text] [Related]

  • 7. Experimental myocardial infarction. X. Efficacy of glucagon in acute and healing phase in intact conscious dogs: effects on hemodynamics and myocardial oxygen consumption.
    Kumar R, Molokhia FA, Norman JC, Inamdar AN, Messer JV, Abelmann WH, Hood WB, Sharma GV.
    Circulation; 1972 Jan 28; 45(1):55-64. PubMed ID: 5007038
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Experience with using glucagon in acute myocardial infarct].
    Golikov AP, Berestov AA, Abdrakhmanov VR, Bobkov AI.
    Kardiologiia; 1974 Feb 28; 14(2):37-42. PubMed ID: 4825009
    [No Abstract] [Full Text] [Related]

  • 14. [Combined use of glucagon and strophanthin in myocardial infarct complicated by severe cardiac insufficiency].
    Riabinin VA, Golikov AP.
    Kardiologiia; 1978 Jan 28; 18(1):62-8. PubMed ID: 342797
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Glucagon in cardiogenic shock].
    De Ninno F, Celentano V, Giugliano F.
    Minerva Anestesiol; 1971 May 28; 37(5):240-6. PubMed ID: 5110768
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Importance of regional circulation for treatment of cardiogenic shock].
    Schröder R.
    Arzneimittelforschung; 1969 May 28; 19(5):797-9. PubMed ID: 4308254
    [No Abstract] [Full Text] [Related]

  • 20. [The effects of oxyfedrine on the hemodynamics of patients with acute myocardial infarction].
    Rettig G, Sternitzke N, Hufnagl HD, Fröhlig G, Schieffer H, Bette L.
    Minerva Med; 1978 Nov 30; 69(58):3968-75. PubMed ID: 740288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.